The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways

Molecular Biology of the Cell

Volumn 19, Issue 7, 2008, Pages 2729-2740

  Cheung, Herman H ^a   Plenchette, Stéphanie ^a   Kern, Chris J ^a   Mahoney, Douglas J ^a   Korneluk, Robert G ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CISPLATIN; DOXORUBICIN; FAS LIGAND; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN LIVIN; UBIQUITIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; UBIQUITINATION;

APOPTOSIS; DOWN-REGULATION; FAS LIGAND PROTEIN; GENES, DOMINANT; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MUTAGENESIS; MUTATION; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; UBIQUITIN;

INTRACISTERNAL A-PARTICLES;

EID: 51349130944     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-01-0107     Document Type: Article

References (40)

1. Algeciras-Schimnich, A., Pietras, E. M., Barnhart, B. C., Legembre, P., Vijayan, S., Holbeck, S. L., and Peter, M. E. (2003). Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc. Natl. Acad. Sci. USA 100, 11445-11450.
2. Arora, V., Cheung, H. H., Plenchette, S., Micali, O. C., Liston, P., and Korneluk, R. G. (2007). Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex. J. Biol. Chem. 282, 26202-26209.
3. Chang, H., and Schimmer, A. D. (2007). Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy. Mol. Cancer Ther. 6, 24-30.
4. Chen, Z. J. (2005). Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 7, 758-765.
5. Cheung, H. H., and Gurd, J. W. (2001). Tyrosine phosphorylation of the N-methyl-D-aspartate receptor by exogenous and postsynaptic density-associated Src-family kinases. J. Neurochem. 78, 524-534.
6. Cheung, H. H., LaCasse, E. C., and Korneluk, R. G. (2006a). X-linked inhibitor of apoptosis antagonism: strategies in cancer treatment. Clin. Cancer Res. 12, 3238-3242.
7. Cheung, H. H., Lynn Kelly, N., Liston, P., and Korneluk, R. G. (2006b). Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp. Cell Res. 312, 2347-2357.
8. Ciechanover, A., and Ben-Saadon, R. (2004). N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 14, 103-106.
9. Clem, R. J., Sheu, T. T., Richter, B. W., He, W. W., Thornberry, N. A., Duckett, C. S., and Hardwick, J. M. (2001). c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment. J. Biol. Chem. 276, 7602-7608.
10. Conze, D. B., Albert, L., Ferrick, D. A., Goeddel, D. V., Yeh, W. C., Mak, T., and Ashwell, J. D. (2005). Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell Biol. 25, 3348-3356.
11. Dai, Z. et al. (2003). A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Hum. Mol. Genet. 12, 791-801.
12. Dan, H. C., Sun, M., Kaneko, S., Feldman, R. I., Nicosia, S. V., Wang, H. G., Tsang, B. K., and Cheng, J. Q. (2004). Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J. Biol. Chem. 279, 5405-5412.
13. Dean, E. J., Ranson, M., Blackhall, F., Holt, S. V., and Dive, C. (2007). Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic. Cancer Treat. Rev. 33, 203-212.
14. Dohi, T. et al. (2004). An IAP-IAP complex inhibits apoptosis. J. Biol. Chem. 279, 34087-34090.
15. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42.
16. Eckelman, B. P., and Salvesen, G. S. (2006). The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J. Biol. Chem. 281, 3254-3260.
17. Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
18. Holcik, M., Lefebvre, C. A., Hicks, K., and Korneluk, R. G. (2002). Cloning and characterization of the rat homologues of the inhibitor of apoptosis protein 1, 2, and 3 genes. BMC Genom. 3, 5.
19. Hu, S., and Yang, X. (2003). Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J. Biol. Chem. 278, 10055-10060.
20. Hunter, A. M., LaCasse, E. C., and Korneluk, R. G. (2007). The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12, 1543-1568.
21. Imoto, I., Tsuda, H., Hirasawa, A., Miura, M., Sakamoto, M., Hirohashi, S., and Inazawa, J. (2002). Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. Cancer Res. 62, 4860-4866.
22. Li, J. et al. (2001). Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology 142, 370-380.
23. Liston, P. et al. (1996). Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379, 349-353.
24. Ni, T., Li, W., and Zou, F. (2005). The ubiquitin ligase ability of IAPs regulates apoptosis. IUBMB Life 57, 779-785.
25. Samuel, T., Welsh, K., Lober, T., Togo, S. H., Zapata, J. M., and Reed, J. C. (2006). Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J. Biol. Chem. 281, 1080-1090.
26. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M., Krammer, P. H., and Peter, M. E. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687.
27. Sdek, P., Ying, H., Chang, D. L., Qiu, W., Zheng, H., Touitou, R., Allday, M. J., and Xiao, Z. X. (2005). MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol. Cell 20, 699-708.
28. Sheaff, R. J., Singer, J. D., Swanger, J., Smitherman, M., Roberts, J. M., and Clurman, B. E. (2000). Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell 5, 403-410.
29. Shin, H., Okada, K., Wilkinson, J. C., Solomon, K. M., Duckett, C. S., Reed, J. C., and Salvesen, G. S. (2003). Identification of ubiquitination sites on the X-linked inhibitor of apoptosis protein. Biochem. J. 373, 965-971.
30. Silke, J., Kratina, T., Chu, D., Ekert, P. G., Day, C. L., Pakusch, M., Huang, D. C., and Vaux, D. L. (2005). Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc. Natl. Acad. Sci. USA 102, 16182-16187.
31. Sun, Y. (2006). E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8, 645-654.
32. Varfolomeev, E. et al. (2007). IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131, 669-681.
33. Vaux, D. L., and Silke, J. (2005). IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6, 287-297.
34. Wilkinson, J. C., Wilkinson, A. S., Scott, F. L., Csomos, R. A., Salvesen, G. S., and Duckett, C. S. (2004). Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition. J. Biol. Chem. 279, 51082-51090.
35. Wu, C. J., Conze, D. B., Li, T., Srinivasula, S. M., and Ashwell, J. D. (2006). Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat. Cell Biol. 8, 398-406.
36. Wu, C. J., Conze, D. B., Li, X., Ying, S. X., Hanover, J. A., and Ashwell, J. D. (2005). TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J. 24, 1886-1898.
37. Xie, Y., and Varshavsky, A. (2002). UFD4 lacking the proteasome-binding region catalyses ubiquitination but is impaired in proteolysis. Nat. Cell Biol. 4, 1003-1007.
38. Yang, Q. H., and Du, C. (2004). Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J. Biol. Chem. 279, 16963-16970.
39. Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M., and Ashwell, J. D. (2000). Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874-877.
40. Zender, L. et al. (2006). Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253-1267.